Cigna Group $CI Stock Position Lessened by Curated Wealth Partners LLC

Key Points

• Curated Wealth Partners cut its Cigna stake by 99.8% in the third quarter, selling 463,409 shares and retaining just 748 shares valued at approximately $203,000.
• Cigna reported quarterly earnings of $7.78 per share, exceeding estimates of $7.60, while revenue rose 6.7% year over year to $71.56 billion. The company maintained FY 2026 earnings guidance of about $30.45 per share.
• Analysts maintain a generally positive view, with a “Moderate Buy” consensus and an average price target of $338.24, compared with the stock’s reported price of $302.48. Cigna also pays a quarterly dividend of $1.56, representing a 2.1% yield.

Curated Wealth Partners LLC reduced its holdings in shares of Cigna Group (NYSE:CI - Free Report) by 99.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 748 shares of the health services provider's stock after selling 463,409 shares during the quarter. Curated Wealth Partners LLC's holdings in Cigna Group were worth $203,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in CI. Osbon Capital Management LLC acquired a new position in Cigna Group during the 2nd quarter valued at about $26,000. Cedar Mountain Advisors LLC raised its stake in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock worth $29,000 after purchasing an additional 68 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Cigna Group in the second quarter worth approximately $29,000. Fiduciary Financial Advisors bought a new position in shares of Cigna Group in the second quarter valued at approximately $29,000. Finally, ANTIPODES PARTNERS Ltd bought a new position in shares of Cigna Group in the second quarter valued at approximately $34,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Performance

Shares of CI stock opened at $302.48 on Monday. The firm has a market cap of $79.93 billion, a price-to-earnings ratio of 12.51, a P/E/G ratio of 1.02 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52 week low of $239.51 and a 52 week high of $311.34. The firm's 50-day simple moving average is $278.87 and its two-hundred day simple moving average is $281.99.

Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $71.56 billion for the quarter, compared to analysts' expectations of $70.14 billion. During the same period in the previous year, the company earned $7.20 earnings per share. The company's quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts forecast that Cigna Group will post 30.50 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were paid a $1.56 dividend. The ex-dividend date was Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group's payout ratio is presently 25.82%.

Analysts Set New Price Targets

CI has been the topic of several analyst reports. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cigna Group in a research report on Thursday, August 27th. Wells Fargo & Company increased their price target on Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Royal Bank Of Canada restated an "outperform" rating and set a $337.00 price objective on shares of Cigna Group in a research note on Thursday, October 1st. Wall Street Zen upgraded Cigna Group from a "hold" rating to a "buy" rating in a research note on Saturday, September 26th. Finally, Raymond James Financial downgraded shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and cut their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $338.24.

Insider Buying and Selling at Cigna Group

In related news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company's stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the business's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares in the company, valued at $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 22,730 shares of company stock worth $6,293,359. Corporate insiders own 0.60% of the company's stock.

Cigna Group Profile

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.